LPAR2 and inflammatory bowel disease: It is plausible that more severe tissue inflammation at a later more advanced disease stage of enteropathy might overcome the direct effects of IND resulting in increased ATX and LPAR2 expression, similarly to the changes reported in inflammatory bowel disease and animal models of colitis [22, 33, 69, 75, 76].